
    
      Enrolled participants will be randomized (2:1) to receive either verofilcon A (test) contact
      lenses or delefilcon A (control) contact lenses for wear in both eyes and attend 7 office
      visits: Baseline, Dispense, 1-week follow-up, 2-week follow-up, 1-month follow-up, 2-month
      follow-up and 3-month follow-up/Exit.
    
  